175 related articles for article (PubMed ID: 34629798)
1.
Lee CC; Kuo YC; Hu JM; Chang PK; Sun CA; Yang T; Li CW; Chen CY; Lin FH; Hsu CH; Chou YC
World J Gastroenterol; 2021 Sep; 27(34):5737-5752. PubMed ID: 34629798
[TBL] [Abstract][Full Text] [Related]
2. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
3. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review.
Li Y; Lyu Z; Zhao L; Cheng H; Zhu D; Gao Y; Shang X; Shi H
Tumour Biol; 2015 Mar; 36(3):1595-601. PubMed ID: 25596081
[TBL] [Abstract][Full Text] [Related]
6. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.
Abouzeid HE; Kassem AM; Abdel Wahab AH; El-mezayen HA; Sharad H; Abdel Rahman S
Tumour Biol; 2011 Oct; 32(5):845-52. PubMed ID: 21274674
[TBL] [Abstract][Full Text] [Related]
8. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
[TBL] [Abstract][Full Text] [Related]
9. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma.
Chen J; Huang ZJ; Duan YQ; Xiao XR; Jiang JQ; Zhang R
Asian Pac J Cancer Prev; 2012; 13(10):5303-6. PubMed ID: 23244153
[TBL] [Abstract][Full Text] [Related]
10. The association of methylation in the promoter of APC and MGMT and the prognosis of Taiwanese CRC patients.
Chen SP; Chiu SC; Wu CC; Lin SZ; Kang JC; Chen YL; Lin PC; Pang CY; Harn HJ
Genet Test Mol Biomarkers; 2009 Feb; 13(1):67-71. PubMed ID: 19309276
[TBL] [Abstract][Full Text] [Related]
11. MTNR1B genetic polymorphisms as risk factors for gestational diabetes mellitus: a case-control study in a single tertiary care center.
Alharbi KK; Al-Sulaiman AM; Shedaid KMB; Al-Shangiti AM; Marie M; Al-Sheikh YA; Ali Khan I
Ann Saudi Med; 2019; 39(5):309-318. PubMed ID: 31580701
[TBL] [Abstract][Full Text] [Related]
12. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
Shima K; Morikawa T; Baba Y; Nosho K; Suzuki M; Yamauchi M; Hayashi M; Giovannucci E; Fuchs CS; Ogino S
Cancer Causes Control; 2011 Feb; 22(2):301-9. PubMed ID: 21140203
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic variants of melatonin receptor 1B with gestational plasma glucose level and risk of glucose intolerance in pregnant Chinese women.
Liao S; Liu Y; Tan Y; Gan L; Mei J; Song W; Chi S; Dong X; Chen X; Deng S
PLoS One; 2012; 7(7):e40113. PubMed ID: 22768333
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma.
Funakoshi Y; Hata N; Takigawa K; Arita H; Kuga D; Hatae R; Sangatsuda Y; Fujioka Y; Sako A; Umehara T; Yoshitake T; Togao O; Hiwatashi A; Yoshimoto K; Iwaki T; Mizoguchi M
Cancer Med; 2021 May; 10(10):3177-3187. PubMed ID: 33838014
[TBL] [Abstract][Full Text] [Related]
15. Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.
Sinha R; Hussain S; Mehrotra R; Kumar RS; Kumar K; Pande P; Doval DC; Basir SF; Bharadwaj M
PLoS One; 2013; 8(4):e60142. PubMed ID: 23573237
[TBL] [Abstract][Full Text] [Related]
16. Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value.
Krtolica K; Krajnovic M; Usaj-Knezevic S; Babic D; Jovanovic D; Dimitrijevic B
World J Gastroenterol; 2007 Feb; 13(8):1187-94. PubMed ID: 17451198
[TBL] [Abstract][Full Text] [Related]
17. Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer.
Dallol A; Al-Maghrabi J; Buhmeida A; Gari MA; Chaudhary AG; Schulten HJ; Abuzenadah AM; Al-Ahwal MS; Sibiany A; Al-Qahtani MH
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2069-75. PubMed ID: 23010642
[TBL] [Abstract][Full Text] [Related]
18. Relationship between melatonin receptor 1B (rs10830963 and rs1387153) with gestational diabetes mellitus: a case-control study and meta-analysis.
Liu Q; Huang Z; Li H; Bai J; Liu X; Ye H
Arch Gynecol Obstet; 2016 Jul; 294(1):55-61. PubMed ID: 26563312
[TBL] [Abstract][Full Text] [Related]
19. Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
Schwartz S; Szeto C; Tian Y; Cecchi F; Corallo S; Calegari MA; Di Bartolomeo M; Morano F; Raimondi A; Fucà G; Martinetti A; De Pascalis I; Martini M; Belfiore A; Milione M; Orlandi A; Barault L; Barone C; de Braud F; Di Nicolantonio F; Benz S; Hembrough T; Pietrantonio F
Eur J Cancer; 2019 Jan; 107():164-174. PubMed ID: 30579113
[TBL] [Abstract][Full Text] [Related]
20. Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.
Taioli E; Ragin C; Wang XH; Chen J; Langevin SM; Brown AR; Gollin SM; Garte S; Sobol RW
BMC Cancer; 2009 Oct; 9():354. PubMed ID: 19807915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
